Yale Study Identifies 80 Genetic Links to Endometriosis

For women with endometriosis, the average wait for a diagnosis is a frustrating decade. Yale researchers just delivered hope that could change everything.

In the largest genetic study of endometriosis ever conducted, an international team analyzed genomes from more than 1.4 million women across diverse ancestry groups. They identified 80 genomic regions linked to the painful condition, with 37 being brand new discoveries that scientists had never connected to the disease before.

Endometriosis affects roughly 10% of women worldwide. The condition causes tissue similar to the uterine lining to grow outside the uterus, triggering chronic pain, migraines, and a cascade of debilitating symptoms that often take years to diagnose correctly.

"This research provides the most complete map so far of the biological mechanisms behind the disease," said Dr. Renato Polimanti, associate professor of psychiatry at Yale School of Medicine and senior author of the study published in Nature Genetics. The team included over 105,000 women diagnosed with endometriosis, making it powerful enough to spot genetic patterns invisible in smaller studies.

The discoveries point toward immediate practical applications. Researchers identified several FDA-approved drugs already used for breast cancer, contraception, and preventing preterm birth that might be repurposed to treat endometriosis.

The study also found five genetic regions shared between endometriosis and adenomyosis, a related condition where tissue grows into the uterine wall. This overlap helps clarify whether these are truly separate diseases or variations of the same underlying process.

Why This Inspires

What makes this research particularly meaningful is its global reach. By including participants from diverse population groups, the team showed that while the core biology of endometriosis remains consistent worldwide, specific genetic variations may influence how the disease appears in different communities.

Lead author Dr. Dora Koller emphasized that the findings provide molecular support for leading theories about what causes endometriosis. The genetic data points to inflammation, hormonal regulation, and tissue remodeling as key drivers, giving scientists clear targets for developing better treatments.

The research team used cutting-edge "multi-omics" technology, combining genetics with protein and tissue analysis to understand not just which genes matter, but how they actually influence the disease. While a genetic test for endometriosis isn't ready for doctor's offices yet, these ancestry-informed risk models represent a significant leap toward personalized medicine for millions of women.

After decades of diagnostic delays and limited treatment options, women with endometriosis finally have a roadmap toward faster answers and better care.